Efficacy, tolerability and safety of the treatment with teberif: the results of a 2-year randomized clinical trial of treatment naïve patients with remitting multiple sclerosis, who have not received DMT, after switching from other interferon β-1a
Boyko, A N, Bosenko, L P, Vasilovskiy, V V, Volkova, L I, Zakharova, M N, Kotov, S V, Lekomtseva, E V, Negrich, T I, Parshina, E V, Patrusheva, O P, Prokopenko, S V, Sazonov, D V, Timchenko, L V, Trinitatskiy, Yu V, Khabirov, F A, Khavunka, M Ya, Chichanovskaya, L V, Sherman, M A, Ivanov, R A, Lin'kova, Yu N, Stukalina, E Yu, Zinkina-Orikhan, A V, Obukhova, I G
Published in Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2019)
Published in Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2019)
Get more information
Journal Article